← FDA Drug Approvals (Drugs@FDA)

IMATINIB MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHILPA · Approved 2019-01-17

Drug application

FDA Application #

ANDA208302

Application type

Abbreviated New Drug Application (Generic)

Brand name

IMATINIB MESYLATE

Generic name

IMATINIB MESYLATE

Active ingredients

IMATINIB MESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SHILPA

Manufacturer

Ascend Laboratories, LLC

First approval

2019-01-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown